Laxminarayan Bhat
Founder, CEO, President & DirectorDr. Laxminarayan Bhat, Ph.D., is the Founder and Director of Reviva Pharmaceuticals Holdings, Inc. since December 2020 and has been its President and Chief Executive Officer since December 2020. Prior to this, Dr. Bhat served as President, Chief Executive Officer and a director of Reviva Pharmaceuticals, Inc. since its inception in 2006. At Reviva, Dr. Bhat has developed and implemented innovative financing and business models with strategies that have greatly accelerated the drug discovery and development process, resulting in significant savings of time and costs but without sacrificing quality. Dr. Bhat has experience in drug discovery and development. From 2000 to 2004, Dr. Bhat served as research scientist at XenoPort, Inc., now a part of Arbor Pharmaceuticals, LLC. Dr. Bhat also served as a research scientist at ARYx Therapeutics Inc. from 2004 to 2006. From 1997 to 2000, Dr. Bhat served as a post-doctoral researcher in the Drug Discovery Program at the Higuchi Biosciences Center. In 1995, he was selected for the Alexander von Humboldt fellowship to pursue advanced research in Germany. Dr. Bhat is an inventor on more than 100 filed patents and over 35 granted patents. He has authored over 15 research papers published in peer-reviewed scientific journals. Dr. Bhat has received a global post-doctoral training at the University of Kansas, USA, the Georg-August-Universität, Göttingen, Germany and the Université du Maine, France. Dr. Bhat received his Ph.D. in synthetic organic chemistry from the Central University (NEHU), India.
Positions
- Company NameReviva Pharmaceuticals Holdings, Inc.Stock CodeRVPHPositionFounder, CEO, President & Director
